Endurant Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-180,429
| Closed | -$19.5M | – | 65 |
|
|
2021
Q3 | $19.5M | Buy |
180,429
+94,915
| +111% | +$10.2M | 4.43% | 2 |
|
|
2021
Q2 | $9.63M | Sell |
85,514
-2,468
| -3% | -$278K | 2.65% | 10 |
|
|
2021
Q1 | $9.52M | Buy |
87,982
+3,438
| +4% | +$372K | 2.48% | 14 |
|
|
2020
Q4 | $9.06M | Sell |
84,544
-114,377
| -57% | -$12.3M | 3.27% | 5 |
|
|
2020
Q3 | $17.4M | Buy |
198,921
+136,306
| +218% | +$11.9M | 5.15% | 4 |
|
|
2020
Q2 | $6.15M | Buy |
+62,615
| New | +$6.15M | 0.34% | 15 |
|
|
2020
Q1 | – | Sell |
-98,596
| Closed | -$8.73M | – | 52 |
|
|
2019
Q4 | $8.73M | Sell |
98,596
-63,411
| -39% | -$5.61M | 2.75% | 13 |
|
|
2019
Q3 | $12.3M | Buy |
162,007
+72,999
| +82% | +$5.53M | 4.4% | 9 |
|
|
2019
Q2 | $6.47M | Buy |
89,008
+67,334
| +311% | +$4.9M | 2.55% | 18 |
|
|
2019
Q1 | $1.75M | Buy |
+21,674
| New | +$1.75M | 0.69% | 41 |
|
|
2016
Q2 | – | Sell |
-6,700
| Closed | -$383K | – | 89 |
|
|
2016
Q1 | $383K | Sell |
6,700
-80,600
| -92% | -$4.61M | 0.12% | 77 |
|
|
2015
Q4 | $5.17M | Buy |
87,300
+70,900
| +432% | +$4.2M | 1.73% | 18 |
|
|
2015
Q3 | $892K | Buy |
+16,400
| New | +$892K | 0.3% | 61 |
|
|
2015
Q1 | – | Sell |
-33,301
| Closed | -$2.18M | – | 97 |
|
|
2014
Q4 | $2.18M | Buy |
+33,301
| New | +$2.18M | 0.85% | 41 |
|